Narcolepsy trials in France
19 of 22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Not yet taking people in FranceA Study to Investigate the Effects of Cleminorexton Compared with Placebo in the Treatment of Participants with Central Disorders of Hypersomnolence
- Where
- Angers, Bordeaux, Montpellier Cedex 5, Paris, Strasbourg Cedex, Tours
- Age
- 18 years and over
- People
- 168 worldwide
- Run by
- Centessa Pharmaceuticals UK Limited
See details and how to join2026-525961-37-00 - Phase 2/3Taking peopleA Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Where
- Bordeaux, Grenoble Cedex 9, Lyon Cedex 04, Montpellier Cedex 5, Saint-Herblain, Toulouse
- Age
- 18 years to 70 years
- People
- 786 worldwide
- Run by
- Alkermes, Inc.
See details and how to joinNCT06767683 · EU 2024-519822-18-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Where
- Bordeaux, Lyon Cedex 04, Montpellier Cedex 5, Saint-Herblain, Toulouse
- Age
- 18 years and over
- People
- 116 worldwide
- Run by
- Alkermes Inc.
See details and how to join2025-524711-36-00 - Phase 2Taking peopleA Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
- Where
- Paris Cedex 13
- Age
- 18 years to 70 years
- People
- 88 worldwide
- Run by
- Takeda
See details and how to joinNCT06952699 · EU 2024-517711-70-01 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Where
- Bordeaux, Lyon, Montpellier
- Age
- 18 years to 70 years
- People
- 150 worldwide
- Run by
- Alkermes, Inc.
See details and how to joinNCT07455383 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Where
- Bordeaux, Lyon, Montpellier
- Age
- 18 years to 70 years
- People
- 176 worldwide
- Run by
- Alkermes, Inc.
See details and how to joinNCT07502443 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Where
- Bordeaux, Lyon Cedex 04, Montpellier Cedex 5, Saint-Herblain, Toulouse
- Age
- 18 years and over
- People
- 115 worldwide
- Run by
- Alkermes Inc.
See details and how to join2025-523911-13-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Where
- Bordeaux, Lyon Cedex 04, Montpellier Cedex 5
- Age
- 18 years and over
- People
- 132 worldwide
- Run by
- Alkermes Inc.
See details and how to join2025-523912-35-00 - Phase 3Taking peopleA Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Where
- Grenoble Cedex 9, Montpellier Cedex 5, Nimes Cedex 9, Toulouse
- Age
- 18 years and over
- People
- 258 worldwide
- Run by
- Harmony Biosciences Management, Inc.
See details and how to joinNCT07675135 · EU 2025-523821-17-00 - No phaseNot yet taking people in FranceHypersomnia in the Paediatric Population
- Where
- Montpellier
- Age
- 6 years to 17 years
- People
- 760
- Run by
- University Hospital, Montpellier
See details and how to joinNCT07766343 - Phase 2Taking peopleA Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
- Where
- Montpellier Cedex 5, Paris
- Age
- 18 years to 70 years
- People
- 92 worldwide
- Run by
- Takeda
See details and how to joinNCT07633301 · EU 2025-522587-33-00 - No phaseTaking peopleDeciphering the Interactions Between Food Intake, Sleepiness, and Nighttime Sleep Quality in Patients With Type 1 Narcolepsy and Idiopathic Hypersomnia
- Where
- Clermont-Ferrand, Lyon
- Age
- 18 years to 65 years
- People
- 76
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT06484348 - No phaseTaking peopleEvaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia
- Where
- Amiens
- Age
- 18 years and over
- People
- 75
- Run by
- Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT05773872 - No phaseTaking peoplePain Assessment in Patients With Idiopathic Rapid Eye Movement (REM) Sleep Behaviour Disorder
- Where
- Toulouse
- Age
- 18 years and over
- People
- 24
- Run by
- University Hospital, Toulouse
See details and how to joinNCT07365566 - Phase 2Taking peopleA Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Where
- Bordeaux, Montpellier Cedex 5
- Age
- 18 years to 65 years
- People
- 248 worldwide
- Run by
- Centessa Pharmaceuticals (UK) Limited
See details and how to joinNCT06752668 · EU 2024-518929-15-00 - Phase 2Taking peopleA Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Where
- Bordeaux, Montpellier Cedex 5
- Age
- 18 years to 65 years
- People
- 90 worldwide
- Run by
- Centessa Pharmaceuticals (UK) Limited
See details and how to joinNCT07096674 · EU 2025-522987-34-00 - Phase 2/3Taking peopleA Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
- Where
- Bordeaux, Lyon Cedex 04, Marseille, Montpellier Cedex 5, Paris, Saint-Herblain, Toulouse
- Age
- 16 years to 70 years
- People
- 500 worldwide
- Run by
- Takeda
See details and how to joinNCT05816382 · EU 2023-508462-15-00 - Phase 2/3Taking peopleCIRAANO: Multimodal exploration of theater actors, memory athletes, and patients with various memory pathologies: evaluation of mnesic strategies and their cerebral substrates, and contribution to the treatment of memory pathologies.
- Where
- Caen
- Age
- 18 years and over
- People
- 600
- Run by
- Institut National De La Sante Et De La Recherche Medicale
See details and how to join2025-523264-21-00 - No phaseTaking peopleMind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions
- Where
- Lyon
- Age
- 18 years to 65 years
- People
- 180
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT06457945